1区 · 医学
Article
作者: Cui, Shuaiying ; Jearawiriyapaisarn, Natee ; Lee, Mary ; Iwase, Shigeki ; Campbell, Andrew ; Lavelle, Donald ; Myers, Greggory ; Lim, Kim-Chew ; Engel, James Douglas ; Saunthararajah, Yogen ; Harro, David ; DeSimone, Joseph ; Shi, Lihong ; Rivers, Angela ; Trievel, Raymond C.
Key PointsRN-1 treatment of SCD mice results in increased human fetal γ-globin induction and fetal hemoglobin synthesis. RN-1 treatment of SCD mice significantly reduces sickling, hemolysis, and tissue injury with no obvious adverse side effects.